Community Health Systems (CYH) Financials

$3.67 -0.05 (-1.34%)

Closing price 05/23/2025 03:59 PM Eastern

Extended Trading

$3.66 0.00 (-0.14%)

As of 05/23/2025 05:29 PM Eastern

Annual Income Statements for Community Health Systems

This table shows Community Health Systems' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-516	-133	46
Consolidated Net Income / (Loss)	-362	16	179
Net Income / (Loss) Continuing Operations	-362	16	179
Total Pre-Tax Income	-283	207	349
Total Operating Income	542	957	821
Total Gross Profit	4,971	5,082	4,589
Total Revenue	12,634	12,490	12,211
Operating Revenue	12,634	12,490	12,211
Total Cost of Revenue	7,663	7,408	7,622
Operating Cost of Revenue	7,663	7,408	7,622
Total Operating Expenses	4,429	4,125	3,768
Selling, General & Admin Expense	3,642	3,388	3,336
Depreciation Expense	486	505	534
Other Operating Expenses / (Income)	0.00	319	-173
Impairment Charge	301	-87	71
Total Other Income / (Expense), net	-825	-750	-472
Interest Expense	-25	-72	-253
Interest & Investment Income	-850	-822	-844
Other Income / (Expense), net	0.00	0.00	119
Income Tax Expense	79	191	170
Net Income / (Loss) Attributable to Noncontrolling Interest	154	149	133
Basic Earnings per Share	($3.90)	($1.02)	$0.35
Weighted Average Basic Shares Outstanding	132.10M	130.45M	128.81M
Diluted Earnings per Share	($3.90)	($1.02)	$0.35
Weighted Average Diluted Shares Outstanding	132.10M	130.45M	130.06M
Weighted Average Basic & Diluted Shares Outstanding	138.92M	136.74M	134.70M

This table shows Community Health Systems' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-13	-71	-391	-13	-41	47	-91	-38	-51	415	-42
Consolidated Net Income / (Loss)	25	-27	-355	26	-6.00	86	-52	2.00	-20	447	0.00
Net Income / (Loss) Continuing Operations	25	-27	-355	26	-6.00	86	-52	2.00	-20	447	0.00
Total Pre-Tax Income	67	64	-419	50	22	194	-33	40	6.00	324	70
Total Operating Income	284	278	-205	238	231	328	173	246	210	228	204
Total Gross Profit	1,298	1,169	1,262	1,255	1,285	1,395	1,259	1,273	1,155	969	1,181
Total Revenue	3,159	3,264	3,090	3,140	3,140	3,181	3,086	3,115	3,108	3,141	3,025
Operating Revenue	3,159	3,264	3,090	3,140	3,140	3,181	3,086	3,115	3,108	3,141	3,025
Total Cost of Revenue	1,861	2,095	1,828	1,885	1,855	1,786	1,827	1,842	1,953	2,172	1,844
Operating Cost of Revenue	1,861	2,095	1,828	1,885	1,855	1,786	1,827	1,842	1,953	2,172	1,844
Total Operating Expenses	1,014	891	1,467	1,017	1,054	1,067	1,086	1,027	945	741	977
Selling, General & Admin Expense	865	905	1,010	882	845	864	853	836	835	825	828
Depreciation Expense	105	129	117	125	115	121	128	124	132	136	137
Other Operating Expenses / (Income)	68	-150	73	0.00	77	160	79	80	0.00	-238	-35
Impairment Charge	-24	7.00	267	10	17	-78	26	-13	-22	18	47
Total Other Income / (Expense), net	-217	-214	-214	-188	-209	-134	-206	-206	-204	96	-134
Interest Expense	0.00	1.00	0.00	-26	0.00	-72	0.00	0.00	0.00	-180	-78
Interest & Investment Income	-217	-213	-214	-214	-209	-206	-206	-206	-204	-203	-212
Income Tax Expense	42	91	-64	24	28	108	19	38	26	-123	70
Net Income / (Loss) Attributable to Noncontrolling Interest	38	44	36	39	35	39	39	40	31	32	42
Basic Earnings per Share	($0.10)	($0.53)	($2.95)	($0.10)	($0.32)	$0.36	($0.69)	($0.29)	($0.40)	$3.20	($0.32)
Weighted Average Basic Shares Outstanding	132.88M	132.10M	132.38M	132.34M	131.27M	130.45M	130.70M	130.66M	129.69M	128.81M	129.14M
Diluted Earnings per Share	($0.10)	($0.53)	($2.95)	($0.10)	($0.32)	$0.36	($0.69)	($0.29)	($0.40)	$3.20	($0.32)
Weighted Average Diluted Shares Outstanding	132.88M	132.10M	132.38M	132.34M	131.27M	130.45M	130.70M	130.66M	129.69M	130.06M	129.14M
Weighted Average Basic & Diluted Shares Outstanding	140.31M	138.92M	138.95M	138.94M	138.97M	136.74M	136.80M	136.79M	136.74M	134.70M	134.71M

This table details how cash moves in and out of Community Health Systems' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	-1.00	-80	-389
Net Cash From Operating Activities	480	210	300
Net Cash From Continuing Operating Activities	480	210	300
Net Income / (Loss) Continuing Operations	-362	16	179
Consolidated Net Income / (Loss)	-362	16	179
Depreciation Expense	486	505	534
Non-Cash Adjustments To Reconcile Net Income	481	44	-99
Changes in Operating Assets and Liabilities, net	-125	-355	-314
Net Cash From Investing Activities	-275	-26	-259
Net Cash From Continuing Investing Activities	-275	-26	-259
Purchase of Property, Plant & Equipment	-360	-467	-415
Acquisitions	-34	-49	-28
Purchase of Investments	-81	-137	-114
Sale of Property, Plant & Equipment	5.00	28	38
Divestitures	174	432	89
Sale and/or Maturity of Investments	80	232	231
Other Investing Activities, net	-59	-65	-60
Net Cash From Financing Activities	-206	-264	-430
Net Cash From Continuing Financing Activities	-206	-264	-430
Repayment of Debt	-5,072	-4,327	-2,430
Payment of Dividends	-158	-142	-130
Issuance of Debt	5,024	4,204	2,125
Issuance of Common Equity	1.00	5.00	13
Other Financing Activities, net	-1.00	-4.00	-8.00
Cash Interest Paid	741	801	835
Cash Income Taxes Paid	-171	-91	-6.00

This table details how cash moves in and out of Community Health Systems' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	394	4.00	-6.00	-9.00	10	-53	-27	-26	26	-182	-46
Net Cash From Operating Activities	120	216	67	101	96	90	29	86	5.00	9.00	137
Net Cash From Continuing Operating Activities	120	216	67	101	96	90	29	86	5.00	9.00	137
Net Income / (Loss) Continuing Operations	25	-28	-354	26	-6.00	86	-52	2.00	-20	446	1.00
Consolidated Net Income / (Loss)	25	-28	-354	26	-6.00	86	-52	2.00	-20	446	1.00
Depreciation Expense	105	129	116	126	115	121	129	123	132	136	137
Non-Cash Adjustments To Reconcile Net Income	25	58	320	47	56	-95	76	37	26	-234	21
Changes in Operating Assets and Liabilities, net	-35	57	-15	-98	-69	-22	-124	-76	-133	-339	-22
Net Cash From Investing Activities	444	-143	75	-108	-99	180	-101	-86	-19	-52	30
Net Cash From Continuing Investing Activities	444	-143	75	-108	-99	180	-101	-86	-19	-52	30
Purchase of Property, Plant & Equipment	-85	-109	-70	-88	-93	-110	-130	-105	-122	-131	-93
Acquisitions	0.00	-29	-	-	-5.00	-6.00	-21	-9.00	-13	-1.00	-15
Purchase of Investments	-22	-27	-31	-19	-4.00	-11	-27	-73	-26	-41	-18
Sale of Property, Plant & Equipment	0.00	-	1.00	3.00	1.00	1.00	3.00	19	5.00	8.00	23
Divestitures	563	-	174	-	0.00	309	12	19	92	86	-
Sale and/or Maturity of Investments	23	26	22	20	12	11	84	76	61	48	142
Other Investing Activities, net	-35	-4.00	-21	-24	-10	-14	-22	-13	-16	-21	-9.00
Net Cash From Financing Activities	-170	-69	-148	-2.00	13	-323	45	-26	40	-139	-213
Net Cash From Continuing Financing Activities	-170	-69	-148	-2.00	13	-323	45	-26	40	-139	-213
Repayment of Debt	-1,088	-1,144	-806	-2,237	-885	-2,175	-695	-700	-757	-674	-190
Payment of Dividends	-35	-34	-38	-36	-50	-33	-25	-39	-45	-23	-33
Issuance of Debt	954	1,108	696	2,270	950	1,884	764	712	844	555	1.00
Issuance of Common Equity	0.00	-	-	1.00	0.00	1.00	1.00	1.00	2.00	3.00	9.00
Other Financing Activities, net	-1.00	1.00	-	-	-2.00	-	-	-	-4.00	-	-
Cash Interest Paid	229	179	202	211	149	218	198	188	197	221	204
Cash Income Taxes Paid	80	-39	-48	-84	0.00	-30	-24	-37	0.00	-	-

This table presents Community Health Systems' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	14,054	14,455	14,669
Total Current Assets	3,301	3,208	3,082
Cash & Equivalents	37	38	118
Accounts Receivable	2,286	2,231	2,040
Inventories, net	331	328	353
Prepaid Expenses	236	260	237
Current Deferred & Refundable Income Taxes	53	76	99
Other Current Assets	358	275	235
Plant, Property, & Equipment, net	4,776	5,207	5,365
Plant, Property & Equipment, gross	9,160	9,511	9,639
Accumulated Depreciation	4,384	4,304	4,274
Total Noncurrent Assets	5,977	6,040	6,222
Goodwill	3,789	3,958	4,166
Noncurrent Deferred & Refundable Income Taxes	13	29	49
Other Noncurrent Operating Assets	2,175	2,053	2,007
Total Liabilities & Shareholders' Equity	14,054	14,455	14,669
Total Liabilities	15,371	15,279	15,403
Total Current Liabilities	2,345	2,142	2,186
Short-Term Debt	20	21	21
Accounts Payable	913	912	773
Accrued Expenses	479	354	418
Current Employee Benefit Liabilities	596	571	637
Other Current Liabilities	115	124	148
Other Current Nonoperating Liabilities	222	160	189
Total Noncurrent Liabilities	13,026	13,137	13,217
Long-Term Debt	11,432	11,466	11,614
Noncurrent Deferred & Payable Income Tax Liabilities	231	369	354
Other Noncurrent Operating Liabilities	1,363	1,302	1,249
Commitments & Contingencies	0.00	0.00	0.00
Redeemable Noncontrolling Interest	359	323	541
Total Equity & Noncontrolling Interests	-1,676	-1,147	-1,275
Total Preferred & Common Equity	-1,914	-1,392	-1,367
Preferred Stock	0.00	0.00	0.00
Total Common Equity	-1,914	-1,392	-1,367
Common Stock	2,176	2,186	2,085
Retained Earnings	-4,080	-3,564	-3,431
Accumulated Other Comprehensive Income / (Loss)	-10	-14	-21
Noncontrolling Interest	238	245	92

This table presents Community Health Systems' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	13,890	13,905	14,411	14,417	14,674	14,648	14,623	14,914
Total Current Assets	3,407	3,108	3,199	3,175	3,248	3,192	3,114	3,269
Cash & Equivalents	431	33	39	48	91	118	144	300
Accounts Receivable	2,326	2,043	2,195	2,194	2,160	2,043	2,043	1,969
Inventories, net	328	311	337	329	325	333	345	355
Prepaid Expenses	261	227	244	263	249	259	276	246
Current Deferred & Refundable Income Taxes	0.00	92	92	34	98	100	79	98
Other Current Assets	61	402	292	307	325	339	227	301
Plant, Property, & Equipment, net	4,742	4,964	5,222	5,219	5,160	5,250	5,255	5,450
Plant, Property & Equipment, gross	9,200	9,094	9,594	9,607	9,367	9,527	9,560	9,727
Accumulated Depreciation	4,458	4,130	4,372	4,388	4,207	4,277	4,305	4,277
Total Noncurrent Assets	5,741	5,833	5,990	6,023	6,266	6,206	6,254	6,195
Goodwill	3,785	3,940	3,972	3,957	3,943	4,054	4,051	4,201
Noncurrent Deferred & Refundable Income Taxes	13	29	29	29	49	49	49	53
Other Noncurrent Operating Assets	1,943	1,864	1,989	2,037	2,274	2,103	2,154	1,941
Total Liabilities & Shareholders' Equity	13,890	13,905	14,411	14,417	14,674	14,648	14,623	14,914
Total Liabilities	15,219	15,175	15,290	15,295	15,567	15,468	15,414	16,092
Total Current Liabilities	2,370	2,126	2,172	2,136	2,149	2,076	2,132	2,383
Short-Term Debt	29	20	27	34	22	30	39	21
Accounts Payable	974	842	896	941	837	736	712	820
Accrued Expenses	483	493	378	335	472	427	463	572
Current Deferred & Payable Income Tax Liabilities	96	-	-	-	-	-	-	-
Current Employee Benefit Liabilities	478	460	499	504	513	560	596	601
Other Current Liabilities	112	113	114	115	121	134	138	151
Other Current Nonoperating Liabilities	198	198	258	207	184	189	184	218
Total Noncurrent Liabilities	12,849	13,049	13,118	13,159	13,418	13,392	13,282	13,709
Long-Term Debt	11,303	11,467	11,504	11,533	11,820	11,728	11,696	11,943
Capital Lease Obligations	535	528	-	546	560	580	588	563
Noncurrent Deferred & Payable Income Tax Liabilities	205	239	351	354	344	362	351	477
Other Noncurrent Operating Liabilities	806	815	1,263	726	694	722	647	726
Redeemable Noncontrolling Interest	364	322	324	329	329	583	561	516
Total Equity & Noncontrolling Interests	-1,693	-1,592	-1,203	-1,207	-1,222	-1,403	-1,352	-1,694
Total Preferred & Common Equity	-1,923	-1,823	-1,441	-1,428	-1,463	-1,489	-1,445	-1,786
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-1,923	-1,823	-1,441	-1,428	-1,463	-1,489	-1,445	-1,786
Common Stock	2,177	2,195	2,191	2,193	2,171	2,050	2,055	2,092
Retained Earnings	-4,093	-4,010	-3,619	-3,605	-3,611	-3,520	-3,482	-3,845
Accumulated Other Comprehensive Income / (Loss)	-7.00	-8.00	-13	-16	-23	-19	-18	-33
Noncontrolling Interest	230	231	238	221	241	86	93	92

This table displays calculated financial ratios and metrics derived from Community Health Systems' official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	1.15%	2.28%	-1.27%
EBITDA Growth	-29.69%	-0.81%	-24.10%
EBIT Growth	-43.36%	1.81%	-32.95%
NOPAT Growth	412.90%	-82.43%	-59.27%
Net Income Growth	-2,362.50%	-91.06%	-51.36%
EPS Growth	-282.35%	-391.43%	-80.11%
Operating Cash Flow Growth	128.57%	-30.00%	329.01%
Free Cash Flow Firm Growth	223.56%	-74.71%	213.04%
Invested Capital Growth	-4.31%	-1.70%	-5.28%
Revenue Q/Q Growth	0.66%	0.32%	-0.75%
EBITDA Q/Q Growth	-3.93%	6.17%	-4.60%
EBIT Q/Q Growth	-8.45%	11.67%	-7.39%
NOPAT Q/Q Growth	-8.45%	-92.28%	320.96%
Net Income Q/Q Growth	-45.38%	-95.76%	489.13%
EPS Q/Q Growth	-29.57%	-156.04%	123.81%
Operating Cash Flow Q/Q Growth	35.59%	62.79%	225.00%
Free Cash Flow Firm Q/Q Growth	-23.68%	-58.16%	166.91%
Invested Capital Q/Q Growth	-5.41%	-7.04%	-2.62%
Profitability Metrics	-	-	-
Gross Margin	39.35%	40.69%	37.58%
EBITDA Margin	8.14%	11.71%	12.07%
Operating Margin	4.29%	7.66%	6.72%
EBIT Margin	4.29%	7.66%	7.70%
Profit (Net Income) Margin	-2.87%	0.13%	1.47%
Tax Burden Percent	127.92%	7.73%	51.29%
Interest Burden Percent	-52.21%	21.63%	37.13%
Effective Tax Rate	0.00%	92.27%	48.71%
Return on Invested Capital (ROIC)	3.60%	0.68%	3.73%
ROIC Less NNEP Spread (ROIC-NNEP)	-2.78%	0.18%	1.72%
Return on Net Nonoperating Assets (RNNOA)	30.22%	-2.73%	-26.92%
Return on Equity (ROE)	33.82%	-2.05%	-23.19%
Cash Return on Invested Capital (CROIC)	8.00%	2.40%	9.15%
Operating Return on Assets (OROA)	3.80%	6.57%	6.29%
Return on Assets (ROA)	-2.54%	0.11%	1.20%
Return on Common Equity (ROCE)	52.22%	-3.64%	-41.13%
Return on Equity Simple (ROE_SIMPLE)	18.91%	-1.15%	-13.09%
Net Operating Profit after Tax (NOPAT)	379	74	421
NOPAT Margin	3.00%	0.59%	3.45%
Net Nonoperating Expense Percent (NNEP)	6.38%	0.50%	2.01%
Return On Investment Capital (ROIC_SIMPLE)	3.88%	0.72%	4.06%
Cost of Revenue to Revenue	60.65%	59.31%	62.42%
SG&A Expenses to Revenue	28.83%	27.13%	27.32%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	35.06%	33.03%	30.86%
Earnings before Interest and Taxes (EBIT)	542	957	940
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,028	1,462	1,474
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.03	0.03	0.05
Price to Earnings (P/E)	0.00	0.00	12.65
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	7.90%
Enterprise Value to Invested Capital (EV/IC)	1.20	1.15	1.16
Enterprise Value to Revenue (EV/Rev)	0.98	1.00	1.04
Enterprise Value to EBITDA (EV/EBITDA)	12.09	8.51	8.64
Enterprise Value to EBIT (EV/EBIT)	22.93	13.00	13.54
Enterprise Value to NOPAT (EV/NOPAT)	32.76	168.24	30.24
Enterprise Value to Operating Cash Flow (EV/OCF)	25.89	59.26	42.44
Enterprise Value to Free Cash Flow (EV/FCFF)	14.72	47.69	12.34
Leverage & Solvency	-	-	-
Debt to Equity	-8.70	-13.94	-15.85
Long-Term Debt to Equity	-8.68	-13.92	-15.82
Financial Leverage	-10.86	-14.96	-15.61
Leverage Ratio	-13.32	-18.69	-19.36
Compound Leverage Factor	6.95	-4.04	-7.19
Debt to Total Capital	112.99%	107.73%	106.73%
Short-Term Debt to Total Capital	0.20%	0.20%	0.19%
Long-Term Debt to Total Capital	112.80%	107.53%	106.54%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	5.89%	5.33%	5.81%
Common Equity to Total Capital	-18.89%	-13.05%	-12.54%
Debt to EBITDA	11.14	7.86	7.89
Net Debt to EBITDA	11.10	7.83	7.81
Long-Term Debt to EBITDA	11.12	7.84	7.88
Debt to NOPAT	30.18	155.29	27.63
Net Debt to NOPAT	30.09	154.78	27.35
Long-Term Debt to NOPAT	30.13	155.01	27.58
Altman Z-Score	0.72	0.84	0.81
Noncontrolling Interest Sharing Ratio	-54.41%	-77.09%	-77.40%
Liquidity Ratios	-	-	-
Current Ratio	1.41	1.50	1.41
Quick Ratio	0.99	1.06	0.99
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	844	261	1,032
Operating Cash Flow to CapEx	135.21%	47.84%	79.58%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	0.89	0.86	0.82
Accounts Receivable Turnover	5.59	5.85	5.95
Inventory Turnover	23.26	21.76	21.53
Fixed Asset Turnover	2.53	2.36	2.24
Accounts Payable Turnover	8.40	8.79	9.51
Days Sales Outstanding (DSO)	65.25	62.41	61.31
Days Inventory Outstanding (DIO)	15.69	16.78	16.95
Days Payable Outstanding (DPO)	43.46	41.51	38.38
Cash Conversion Cycle (CCC)	37.48	37.67	39.88
Capital & Investment Metrics	-	-	-
Invested Capital	10,320	10,785	10,972
Invested Capital Turnover	1.20	1.15	1.08
Increase / (Decrease) in Invested Capital	-465	-187	-611
Enterprise Value (EV)	12,427	12,445	12,732
Market Capitalization	415	428	582
Book Value per Share	($13.77)	($10.18)	($10.15)
Tangible Book Value per Share	($41.04)	($39.11)	($41.07)
Total Capital	10,135	10,663	10,901
Total Debt	11,452	11,487	11,635
Total Long-Term Debt	11,432	11,466	11,614
Net Debt	11,415	11,449	11,517
Capital Expenditures (CapEx)	355	439	377
Debt-free, Cash-free Net Working Capital (DFCFNWC)	939	1,049	799
Debt-free Net Working Capital (DFNWC)	976	1,087	917
Net Working Capital (NWC)	956	1,066	896
Net Nonoperating Expense (NNE)	741	58	242
Net Nonoperating Obligations (NNO)	11,637	11,609	11,706
Total Depreciation and Amortization (D&A)	486	505	534
Debt-free, Cash-free Net Working Capital to Revenue	7.43%	8.40%	6.54%
Debt-free Net Working Capital to Revenue	7.73%	8.70%	7.51%
Net Working Capital to Revenue	7.57%	8.53%	7.34%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($3.90)	($1.02)	$0.35
Adjusted Weighted Average Basic Shares Outstanding	132.10M	130.45M	128.81M
Adjusted Diluted Earnings per Share	($3.90)	($1.02)	$0.35
Adjusted Weighted Average Diluted Shares Outstanding	132.10M	130.45M	130.06M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	138.92M	136.74M	134.70M
Normalized Net Operating Profit after Tax (NOPAT)	590	609	458
Normalized NOPAT Margin	4.67%	4.88%	3.75%
Pre Tax Income Margin	-2.24%	1.66%	2.86%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	-43.65%	887.50%	72.63%
Augmented Payout Ratio	-43.65%	887.50%	72.63%

This table displays calculated financial ratios and metrics derived from Community Health Systems' official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.61%	2.61%	0.13%	0.80%	1.03%	1.27%	2.02%	6.17%	-0.10%	-2.85%	-2.89%
EBITDA Growth	12.43%	-9.35%	-129.47%	-1.36%	1.17%	23.35%	-11.44%	46.43%	-14.07%	-34.30%	-28.36%
EBIT Growth	22.94%	-15.24%	-218.50%	-3.25%	10.00%	43.86%	-15.20%	106.72%	-22.22%	-45.97%	-40.00%
NOPAT Growth	268.21%	-180.66%	-218.50%	906.18%	91.00%	-53.78%	0.00%	-85.23%	-558.02%	-26.13%	-100.00%
Net Income Growth	516.67%	-131.40%	-582.69%	1,200.00%	70.00%	-80.76%	0.00%	100.67%	-166.67%	101.35%	-100.00%
EPS Growth	68.75%	-247.22%	-327.54%	65.52%	20.00%	-88.75%	-115.63%	88.49%	-3,900.00%	131.88%	-137.65%
Operating Cash Flow Growth	25.00%	140.00%	131.03%	17.44%	1,820.00%	900.00%	-78.83%	62.26%	-95.05%	101.69%	14.17%
Free Cash Flow Firm Growth	939.10%	4.61%	356.43%	1,211.97%	109.85%	-64.09%	84.18%	95.17%	5.82%	160.85%	-929.84%
Invested Capital Growth	-9.56%	-4.31%	-5.96%	-6.20%	-1.54%	-1.70%	2.97%	0.77%	4.21%	-5.28%	13.64%
Revenue Q/Q Growth	-3.22%	5.63%	-1.59%	0.00%	-1.29%	3.08%	-0.93%	0.23%	-1.05%	3.83%	3.10%
EBITDA Q/Q Growth	-4.42%	557.30%	-124.45%	5.20%	-22.94%	48.68%	-18.16%	7.89%	-6.04%	6.74%	35.32%
EBIT Q/Q Growth	2.16%	235.61%	-186.13%	3.03%	-29.57%	89.60%	-29.67%	17.14%	-7.89%	11.76%	71.43%
NOPAT Q/Q Growth	190.36%	18.27%	-215.95%	296.44%	-143.33%	20.07%	884.55%	101.76%	-322.54%	0.00%	-100.00%
Net Income Q/Q Growth	192.59%	92.39%	-1,465.38%	533.33%	-106.98%	265.38%	-2,700.00%	110.00%	-104.47%	0.00%	100.00%
EPS Q/Q Growth	81.13%	82.03%	-2,850.00%	68.75%	-188.89%	152.17%	-137.93%	27.50%	-112.50%	1,100.00%	87.30%
Operating Cash Flow Q/Q Growth	-44.44%	222.39%	-33.66%	5.21%	6.67%	210.34%	-66.28%	1,620.00%	-44.44%	-93.43%	158.49%
Free Cash Flow Firm Q/Q Growth	243.66%	-36.61%	-34.84%	631.97%	-65.40%	255.40%	-182.56%	93.52%	-226.19%	168.46%	13.81%
Invested Capital Q/Q Growth	-0.15%	-5.41%	0.36%	-4.59%	5.65%	-7.04%	0.11%	0.15%	5.47%	-2.62%	-2.03%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	41.09%	35.82%	40.84%	39.97%	40.92%	43.85%	40.80%	40.87%	37.16%	30.85%	39.04%
EBITDA Margin	12.31%	12.47%	-2.88%	11.59%	11.02%	14.12%	9.79%	11.85%	11.00%	11.59%	11.27%
Operating Margin	8.99%	8.52%	-6.63%	7.58%	7.36%	10.31%	5.61%	7.90%	6.76%	7.26%	6.74%
EBIT Margin	8.99%	8.52%	-6.63%	7.58%	7.36%	10.31%	5.61%	7.90%	6.76%	7.26%	6.74%
Profit (Net Income) Margin	0.79%	-0.83%	-11.49%	0.83%	-0.19%	2.70%	-1.69%	0.06%	-0.64%	14.23%	0.00%
Tax Burden Percent	37.31%	-42.19%	84.73%	52.00%	-27.27%	44.33%	157.58%	5.00%	-333.33%	137.96%	0.00%
Interest Burden Percent	23.59%	23.02%	204.39%	21.01%	9.52%	59.15%	-19.08%	16.26%	2.86%	142.11%	34.31%
Effective Tax Rate	62.69%	142.19%	0.00%	48.00%	127.27%	55.67%	0.00%	95.00%	433.33%	-37.96%	100.00%
Return on Invested Capital (ROIC)	3.91%	-4.30%	-5.18%	4.40%	-2.19%	5.25%	4.27%	0.42%	-24.25%	10.84%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	3.23%	-3.53%	-6.89%	3.59%	-1.73%	4.74%	2.88%	0.34%	-18.65%	11.94%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-35.04%	38.27%	78.63%	-51.11%	25.46%	-70.91%	-34.74%	-4.33%	281.34%	-186.40%	0.00%
Return on Equity (ROE)	-31.13%	33.97%	73.45%	-46.71%	23.28%	-65.66%	-30.46%	-3.90%	257.09%	-175.56%	0.00%
Cash Return on Invested Capital (CROIC)	13.88%	8.00%	9.83%	8.40%	2.70%	2.40%	5.45%	6.74%	-1.26%	9.15%	-14.56%
Operating Return on Assets (OROA)	8.04%	7.55%	-5.83%	6.55%	6.34%	8.84%	4.72%	6.59%	5.52%	5.93%	5.43%
Return on Assets (ROA)	0.71%	-0.73%	-10.09%	0.72%	-0.16%	2.32%	-1.42%	0.05%	-0.53%	11.63%	0.00%
Return on Common Equity (ROCE)	-47.26%	52.46%	111.59%	-80.55%	40.07%	-116.28%	-47.79%	-6.37%	453.02%	-311.44%	0.00%
Return on Equity Simple (ROE_SIMPLE)	17.21%	0.00%	13.66%	-3.75%	-2.10%	0.00%	-25.77%	-28.81%	-8.93%	0.00%	2.58%
Net Operating Profit after Tax (NOPAT)	106	-117	-144	124	-63	145	121	12	-700	315	0.00
NOPAT Margin	3.35%	-3.59%	-4.64%	3.94%	-2.01%	4.57%	3.92%	0.39%	-22.52%	10.01%	0.00%
Net Nonoperating Expense Percent (NNEP)	0.68%	-0.78%	1.71%	0.81%	-0.46%	0.51%	1.39%	0.08%	-5.60%	-1.10%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	1.04%	-1.20%	-	-	-	1.41%	-	-	-	3.04%	-
Cost of Revenue to Revenue	58.91%	64.19%	59.16%	60.03%	59.08%	56.15%	59.20%	59.13%	62.84%	69.15%	60.96%
SG&A Expenses to Revenue	27.38%	27.73%	32.69%	28.09%	26.91%	27.16%	27.64%	26.84%	26.87%	26.27%	27.37%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	32.10%	27.30%	47.48%	32.39%	33.57%	33.54%	35.19%	32.97%	30.41%	23.59%	32.30%
Earnings before Interest and Taxes (EBIT)	284	278	-205	238	231	328	173	246	210	228	204
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	389	407	-89	364	346	449	302	369	342	364	341
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.03	0.03	0.07	0.04	0.04	0.03	0.03	0.05	0.05	0.05	0.02
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	1.69	2.12	0.00	12.65	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	59.24%	47.20%	0.00%	7.90%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.20	1.20	1.23	1.15	1.15	1.15	1.14	1.16	1.17	1.16	1.16
Enterprise Value to Revenue (EV/Rev)	0.98	0.98	1.07	1.00	1.05	1.00	1.07	1.09	1.11	1.04	1.07
Enterprise Value to EBITDA (EV/EBITDA)	11.58	12.09	12.50	8.57	8.93	8.51	9.64	9.53	10.39	8.64	8.49
Enterprise Value to EBIT (EV/EBIT)	20.85	22.93	22.60	12.91	13.39	13.00	15.49	15.19	17.73	13.54	12.93
Enterprise Value to NOPAT (EV/NOPAT)	29.78	32.76	32.28	55.70	99.52	168.24	13.85	15.58	41.51	30.24	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	24.61	25.89	37.79	39.62	43.50	59.26	102.93	56.92	66.14	42.44	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	8.24	14.72	12.09	13.28	42.30	47.69	21.29	17.34	0.00	12.34	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-8.93	-8.70	-9.46	-13.12	-13.80	-13.94	-13.89	-15.05	-15.58	-15.85	-10.63
Long-Term Debt to Equity	-8.91	-8.68	-9.44	-13.09	-13.76	-13.92	-13.86	-15.01	-15.53	-15.82	-10.62
Financial Leverage	-10.83	-10.86	-11.41	-14.22	-14.76	-14.96	-12.04	-12.67	-15.08	-15.61	-10.73
Leverage Ratio	-12.83	-13.32	-13.21	-17.10	-17.40	-18.69	-14.29	-15.02	-18.56	-19.36	-14.04
Compound Leverage Factor	-3.03	-3.07	-27.01	-3.59	-1.66	-11.06	2.73	-2.44	-0.53	-27.51	-4.82
Debt to Total Capital	112.61%	112.99%	111.82%	108.25%	107.81%	107.73%	107.76%	107.12%	106.86%	106.73%	110.38%
Short-Term Debt to Total Capital	0.28%	0.20%	0.19%	0.25%	0.30%	0.20%	0.19%	0.26%	0.34%	0.19%	0.19%
Long-Term Debt to Total Capital	112.34%	112.80%	111.63%	108.00%	107.51%	107.53%	107.57%	106.86%	106.52%	106.54%	110.19%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	5.64%	5.89%	5.15%	5.28%	4.90%	5.33%	4.95%	5.81%	5.67%	5.81%	5.36%
Common Equity to Total Capital	-18.25%	-18.89%	-16.97%	-13.53%	-12.71%	-13.05%	-12.71%	-12.93%	-12.53%	-12.54%	-15.74%
Debt to EBITDA	11.08	11.14	11.23	7.89	8.26	7.86	9.01	8.71	9.49	7.89	8.11
Net Debt to EBITDA	10.68	11.10	11.20	7.87	8.23	7.83	8.94	8.63	9.38	7.81	7.91
Long-Term Debt to EBITDA	11.05	11.12	11.21	7.87	8.24	7.84	8.99	8.69	9.46	7.88	8.09
Debt to NOPAT	28.49	30.18	28.99	51.29	92.07	155.29	12.94	14.25	37.91	27.63	-65.73
Net Debt to NOPAT	27.46	30.09	28.91	51.12	91.70	154.78	12.84	14.11	37.47	27.35	-64.16
Long-Term Debt to NOPAT	28.42	30.13	28.95	51.17	91.81	155.01	12.91	14.22	37.79	27.58	-65.62
Altman Z-Score	0.67	0.66	0.57	0.68	0.68	0.70	0.65	0.68	0.66	0.65	0.59
Noncontrolling Interest Sharing Ratio	-51.84%	-54.41%	-51.92%	-72.45%	-72.14%	-77.09%	-56.88%	-63.25%	-76.21%	-77.40%	-54.36%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.44	1.41	1.46	1.47	1.49	1.50	1.51	1.54	1.46	1.41	1.37
Quick Ratio	1.16	0.99	0.98	1.03	1.05	1.06	1.05	1.04	1.03	0.99	0.95
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,195	348	549	842	115	332	-214	-76	-1,168	926	-1,352
Operating Cash Flow to CapEx	141.18%	198.17%	97.10%	118.82%	104.35%	82.57%	22.83%	100.00%	4.27%	7.32%	195.71%
Free Cash Flow to Firm to Interest Expense	0.00	347.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	216.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	107.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.89	0.89	0.88	0.86	0.86	0.86	0.84	0.83	0.82	0.82	0.80
Accounts Receivable Turnover	5.60	5.59	5.97	5.92	5.91	5.85	6.03	6.13	5.92	5.95	6.16
Inventory Turnover	23.35	23.26	23.13	21.95	21.69	21.76	21.99	21.75	21.30	21.53	21.00
Fixed Asset Turnover	2.54	2.53	2.48	2.40	2.39	2.36	2.35	2.30	2.26	2.24	2.27
Accounts Payable Turnover	8.01	8.40	8.76	9.01	8.84	8.79	9.02	9.56	9.67	9.51	9.23
Days Sales Outstanding (DSO)	65.19	65.25	61.11	61.64	61.75	62.41	60.53	59.57	61.62	61.31	59.23
Days Inventory Outstanding (DIO)	15.63	15.69	15.78	16.63	16.83	16.78	16.60	16.78	17.14	16.95	17.38
Days Payable Outstanding (DPO)	45.57	43.46	41.67	40.51	41.27	41.51	40.44	38.19	37.73	38.38	39.53
Cash Conversion Cycle (CCC)	35.26	37.48	35.23	37.77	37.31	37.67	36.68	38.17	41.02	39.88	37.08
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	10,305	10,320	10,910	10,871	11,394	10,785	11,602	11,589	11,572	10,972	11,267
Invested Capital Turnover	1.17	1.20	1.12	1.12	1.09	1.15	1.09	1.07	1.08	1.08	1.16
Increase / (Decrease) in Invested Capital	-1,089	-465	-692	-718	-178	-187	335	88	468	-611	1,352
Enterprise Value (EV)	12,405	12,427	13,378	12,521	13,094	12,445	13,278	13,491	13,493	12,732	13,125
Market Capitalization	375	415	843	467	479	428	397	602	660	582	290
Book Value per Share	($13.84)	($13.77)	($13.12)	($10.37)	($10.88)	($10.18)	($10.69)	($10.89)	($10.73)	($10.15)	($13.26)
Tangible Book Value per Share	($41.09)	($41.04)	($41.48)	($38.95)	($41.02)	($39.11)	($39.52)	($40.54)	($40.80)	($41.07)	($44.44)
Total Capital	10,538	10,135	10,745	10,652	11,235	10,663	11,509	11,518	11,532	10,901	11,349
Total Debt	11,867	11,452	12,015	11,531	12,113	11,487	12,402	12,338	12,323	11,635	12,527
Total Long-Term Debt	11,838	11,432	11,995	11,504	12,079	11,466	12,380	12,308	12,284	11,614	12,506
Net Debt	11,436	11,415	11,982	11,492	12,065	11,449	12,311	12,220	12,179	11,517	12,227
Capital Expenditures (CapEx)	85	109	69	85	92	109	127	86	117	123	70
Debt-free, Cash-free Net Working Capital (DFCFNWC)	635	939	969	1,015	1,025	1,049	1,030	1,028	877	799	607
Debt-free Net Working Capital (DFNWC)	1,066	976	1,002	1,054	1,073	1,087	1,121	1,146	1,021	917	907
Net Working Capital (NWC)	1,037	956	982	1,027	1,039	1,066	1,099	1,116	982	896	886
Net Nonoperating Expense (NNE)	81	-90	212	98	-57	59	173	10	-680	-132	0.00
Net Nonoperating Obligations (NNO)	11,634	11,637	12,180	11,750	12,272	11,609	12,495	12,409	12,363	11,706	12,445
Total Depreciation and Amortization (D&A)	105	129	116	126	115	121	129	123	132	136	137
Debt-free, Cash-free Net Working Capital to Revenue	5.02%	7.43%	7.72%	8.09%	8.19%	8.40%	8.27%	8.30%	7.18%	6.54%	4.93%
Debt-free Net Working Capital to Revenue	8.42%	7.73%	7.98%	8.40%	8.57%	8.70%	9.00%	9.25%	8.36%	7.51%	7.37%
Net Working Capital to Revenue	8.20%	7.57%	7.82%	8.19%	8.30%	8.53%	8.83%	9.01%	8.04%	7.34%	7.20%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.10)	($0.53)	($2.95)	($0.10)	($0.32)	$0.36	($0.69)	($0.29)	($0.40)	$3.20	($0.32)
Adjusted Weighted Average Basic Shares Outstanding	132.88M	132.10M	132.38M	132.34M	131.27M	130.45M	130.70M	130.66M	129.69M	128.81M	129.14M
Adjusted Diluted Earnings per Share	($0.10)	($0.53)	($2.95)	($0.10)	($0.32)	$0.36	($0.69)	($0.29)	($0.40)	$3.20	($0.32)
Adjusted Weighted Average Diluted Shares Outstanding	132.88M	132.10M	132.38M	132.34M	131.27M	130.45M	130.70M	130.66M	129.69M	130.06M	129.14M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	140.31M	138.92M	138.95M	138.94M	138.97M	136.74M	136.80M	136.79M	136.74M	134.70M	134.71M
Normalized Net Operating Profit after Tax (NOPAT)	182	200	43	129	174	175	139	163	132	172	176
Normalized NOPAT Margin	5.76%	6.11%	1.40%	4.11%	5.53%	5.50%	4.51%	5.24%	4.23%	5.48%	5.81%
Pre Tax Income Margin	2.12%	1.96%	-13.56%	1.59%	0.70%	6.10%	-1.07%	1.28%	0.19%	10.32%	2.31%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	278.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	-117.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	169.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	-226.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-43.20%	-43.65%	-63.05%	266.67%	490.00%	887.50%	35.01%	32.63%	113.18%	72.63%	-319.57%
Augmented Payout Ratio	-43.20%	-43.65%	-63.05%	266.67%	490.00%	887.50%	35.01%	32.63%	113.18%	72.63%	-319.57%

Frequently Asked Questions About Community Health Systems' Financials

When does Community Health Systems's fiscal year end?

According to the most recent income statement we have on file, Community Health Systems' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Community Health Systems' net income changed over the last 2 years?

Community Health Systems' net income appears to be on an upward trend, with a most recent value of -$362 million in 2024, falling from $179 million in 2022. The previous period was $16 million in 2023. See where experts think Community Health Systems is headed by visiting Community Health Systems' forecast page.

What is Community Health Systems's operating income?

Community Health Systems's total operating income in 2024 was $542 million, based on the following breakdown:

Total Gross Profit: $4.97 billion
Total Operating Expenses: $4.43 billion

How has Community Health Systems revenue changed over the last 2 years?

Over the last 2 years, Community Health Systems' total revenue changed from $12.21 billion in 2022 to $12.63 billion in 2024, a change of 3.5%.

How much debt does Community Health Systems have?

Community Health Systems' total liabilities were at $15.37 billion at the end of 2024, a 0.6% increase from 2023, and a 0.2% decrease since 2022.

How much cash does Community Health Systems have?

In the past 2 years, Community Health Systems' cash and equivalents has ranged from $37 million in 2024 to $118 million in 2022, and is currently $37 million as of their latest financial filing in 2024.

How has Community Health Systems' book value per share changed over the last 2 years?

Over the last 2 years, Community Health Systems' book value per share changed from -10.15 in 2022 to -13.77 in 2024, a change of 35.7%.

Related Companies

This page (NYSE:CYH) was last updated on 5/24/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Community Health Systems (CYH) Financials

Frequently Asked Questions About Community Health Systems' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Community Health Systems (CYH) Financials

Annual Income Statements for Community Health Systems

Quarterly Income Statements for Community Health Systems

Annual Cash Flow Statements for Community Health Systems

Quarterly Cash Flow Statements for Community Health Systems

Annual Balance Sheets for Community Health Systems

Quarterly Balance Sheets for Community Health Systems

Annual Metrics And Ratios for Community Health Systems

Quarterly Metrics And Ratios for Community Health Systems

Frequently Asked Questions About Community Health Systems' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools